drugset
Drugs / Mononuclear cells
last change Mar 2020 re-read 3 minutes ago

Mononuclear cells

also known as MNC

Cell therapy

Developed for
amyotrophic lateral sclerosis
Investigated by
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia · Hospital Universitario Virgen de la Arrixaca · Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca · Public Health Service, Murcia · Red de Terapia Celular · Spanish National Health System

Trials 1

today NCT02286011 · Ph 1
2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02286011 Nov 2014 → Dec 2017 amyotrophic lateral sclerosis Red de Terapia Celular Unknown No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Mononuclear cells “Biological: MNC (Mononuclear cells)” NCT02286011 ↗
Known as MNC ClinicalTrials.gov intervention name — accepted as the source's own label NCT02286011 ↗
Modality Cell therapy “autologous bone marrow mononuclear cells (BMMCs), including stem cells” PMID 32265627 ↗ Mar 2020
Route Intramuscular “intramuscularly implanting autologous bone marrow mononuclear cells (BMMCs), including stem cells” PMID 32265627 ↗ Mar 2020